// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Late Breaking Abstract - Apparent diffusion coefficient by 3He MRI and quantitative emphysema subtypes by CT

Wei Shen - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Helium

Impact of endobronchial valves on patient reported outcomes in severe emphysema

Mark Dransfield - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Predictive variables to obtain a bronchoalveolar lavage of adequate quality in patients with interstitial lung diseases

Pilar Rivera Ortega - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical outcomes and micro-costing of bronchial thermoplasty in severe asthma in the UK

Lisa White - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Efficacy and safety of the 9mm intrabronchial valves (IBV) in patients with advanced emphysema

Konstantina Kontogianni - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Outcomes of daycase medical thoracoscopy and pleurodesis

Adina Tomuta - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Twin Anaemia Polycyth aemia Syndrome

N/A

Mechanisms of action of endobronchial coil treatment

Jorine E. Hartman - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Ambulatory pneumothorax management with 8FG Rocket® Pleural Vent™

Avinash Aujayeb - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pneumothorax

N/A

Endobronchial Ultrasound Transbronchial Needle Aspiration (EBUS-TBNA) versus Flexible 19G Endobronchial Ultrasound Transbronchial Needle (Flex 19G EBUS-TBNA) in the Assessment of Mediastinal and Hilar Lymphadenopathy: a Randomised Trial

Eric Daniel Tenda - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Targeted Lung Denervation modulates the bronchial epithelial transcriptome in COPD

Karthi Srikanthan - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Safety and Feasibility of Metered CryoSpray (MCS) for Patients with Chronic Bronchitis in COPD: 9 Month Results

Justin Garner - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Bronchial thermoplasty induced reduction of airway smooth muscle: results from the randomized controlled TASMA trial

Annika W.M. Goorsenberg - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Dermatan sulfate

Patient satisfaction and perception of indwelling pleural catheters

Sarah Jane Messeder - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Correlation between Performance Status (PS) assessment between clinicians and oncologists in a United Kingdom (UK) District General Hospital (DGH) Lung cancer service

Abdi Ali - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

The utility of Endobronchial Ultrasound-Transbronchial Needle Aspiration (EBUS-TBNA) in Programmed Death Ligand-1 (PDL-1) analysis of Non-Small Cell Lung Cancer (NSCLC)

Fawad Hameed - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

N/A

In whom could we diagnose second primary lung cancers ‘early’?

Richard Lee - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Lung Cancer screening- a need for local adaptation?

Fraser Easton - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Is it useful to analyse all waste material obtained during endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA)?

Vykobie Tharmarajah - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Hitting the target - How well can the negative predictive value of targeted EBUS be measured?

Imran Howell - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

The role of Radiological follow-up protocol in patients with surgically resected Non-Small Cell Lung Cancer

Rashad Salman - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

N/A

Copyright © 2026. QuantiNova All rights reserved